Literature DB >> 8971042

Specific cleavage sites of Nef proteins from human immunodeficiency virus types 1 and 2 for the viral proteases.

J Schorr1, R Kellner, O Fackler, J Freund, J Konvalinka, N Kienzle, H G Kräusslich, N Mueller-Lantzsch, H R Kalbitzer.   

Abstract

Human immunodeficiency virus type 2 (HIV-2) Nef is proteolytically cleaved by the HIV-2-encoded protease. The proteolysis is not influenced by the absence or presence of the N-terminal myristoylation. The main cleavage site is located between residues 39 and 40, suggesting a protease recognition sequence, GGEY-SQFQ. As observed previously for Nef protein from HIV-1, a large, stable core domain with an apparent molecular mass of 30 kDa is produced by the proteolytic activity. Cleavage of Nef from HIV-1 in two domains by its own protease or the protease from HIV-2 is also independent of Nef myristoylation. However, processing of HIV-1 Nef by the HIV-2 protease is less selective than that by the HIV-1 protease: the obtained core fragment is heterogeneous at its N terminus and has an additional cleavage site between amino acids 99 and 100. Preliminary experiments suggest that the full-length Nef of HIV-2 and the core domain are part of the HIV-2 particles, analogous to the situation reported recently for HIV-1.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971042      PMCID: PMC191010     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Importance of the nef gene for maintenance of high virus loads and for development of AIDS.

Authors:  H W Kestler; D J Ringler; K Mori; D L Panicali; P K Sehgal; M D Daniel; R C Desrosiers
Journal:  Cell       Date:  1991-05-17       Impact factor: 41.582

2.  Effect of myristoylation on p27 nef subcellular distribution and suppression of HIV-LTR transcription.

Authors:  G Yu; R L Felsted
Journal:  Virology       Date:  1992-03       Impact factor: 3.616

3.  Isolation, biochemical characterization and crystallization of the p15gag proteinase of myeloblastosis associated virus expressed in E. coli.

Authors:  I Pichová; P Strop; J Sedlácek; F Kaprálek; V Benes; M Trávnícek; L Pavlícková; M Soucek; V Kostka; S Foundling
Journal:  Int J Biochem       Date:  1992-02

4.  Expression and cellular localization of the Nef protein from human immunodeficiency virus-1 in stably transfected B-cells.

Authors:  N Kienzle; M Bachmann; W E Müller; N Müller-Lantzsch
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain.

Authors:  C H Lee; K Saksela; U A Mirza; B T Chait; J Kuriyan
Journal:  Cell       Date:  1996-06-14       Impact factor: 41.582

6.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

7.  Cytoplasmic localization of the HTLV-III 3' orf protein in cultured T cells.

Authors:  G Franchini; M Robert-Guroff; J Ghrayeb; N T Chang; F Wong-Staal
Journal:  Virology       Date:  1986-12       Impact factor: 3.616

8.  Expression of the HIV-1 Nef protein in the baculovirus system: investigation of anti-Nef antibodies response in human sera and subcellular localization of Nef.

Authors:  N Kienzle; M Enders; M Buck; H Siakkou; S Jahn; G Petzold; K E Schneweis; M Bachmann; W E Müller; N Müller-Lantzsch
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

9.  Expression, purification and biochemical characterisation of the human immunodeficiency virus 1 nef gene product.

Authors:  V Wolber; H Rensland; B Brandmeier; M Sagemann; R Hoffmann; H R Kalbitzer; A Wittinghofer
Journal:  Eur J Biochem       Date:  1992-05-01

10.  Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.

Authors:  N J Deacon; A Tsykin; A Solomon; K Smith; M Ludford-Menting; D J Hooker; D A McPhee; A L Greenway; A Ellett; C Chatfield; V A Lawson; S Crowe; A Maerz; S Sonza; J Learmont; J S Sullivan; A Cunningham; D Dwyer; D Dowton; J Mills
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728

View more
  10 in total

1.  Mutational analysis of human immunodeficiency virus type 1 (HIV-1) accessory genes: requirement of a site in the nef gene for HIV-1 replication in activated CD4+ T cells in vitro and in vivo.

Authors:  Y Kawano; Y Tanaka; N Misawa; R Tanaka; J I Kira; T Kimura; M Fukushi; K Sano; T Goto; M Nakai; T Kobayashi; N Yamamoto; Y Koyanagi
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Phosphorylation and proteolytic cleavage of gag proteins in budded simian immunodeficiency virus.

Authors:  Sarah M Rue; Jason W Roos; Patrick M Tarwater; Janice E Clements; Sheila A Barber
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

3.  Nef from human immunodeficiency virus type 1(F12) inhibits viral production and infectivity.

Authors:  O T Fackler; P d'Aloja; A S Baur; M Federico; B M Peterlin
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

Review 4.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

5.  The Antagonism of HIV-1 Nef to SERINC5 Particle Infectivity Restriction Involves the Counteraction of Virion-Associated Pools of the Restriction Factor.

Authors:  Birthe Trautz; Virginia Pierini; Rebecka Wombacher; Bettina Stolp; Amanda J Chase; Massimo Pizzato; Oliver T Fackler
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

6.  Activation of the T-cell receptor signaling pathway by Nef from an aggressive strain of simian immunodeficiency virus.

Authors:  W Luo; B M Peterlin
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

7.  Characterization and molecular basis of the oligomeric structure of HIV-1 nef protein.

Authors:  S Arold; F Hoh; S Domergue; C Birck; M A Delsuc; M Jullien; C Dumas
Journal:  Protein Sci       Date:  2000-06       Impact factor: 6.725

8.  Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity.

Authors:  Edward M Campbell; Rafael Nunez; Thomas J Hope
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

9.  A novel dimer-tetramer transition captured by the crystal structure of the HIV-1 Nef.

Authors:  Pankaj Singh; Gaya Prasad Yadav; Sudeepti Gupta; Anil Kumar Tripathi; Ravishankar Ramachandran; Raj Kamal Tripathi
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

10.  HIV-1 Nef inhibits Protease activity and its absence alters protein content of mature viral particles.

Authors:  Luiza M Mendonça; Sandro C Poeys; Celina M Abreu; Amilcar Tanuri; Luciana J Costa
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.